Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.

Simple item page
dc.contributor.authorNagral, Aabhaen_US
dc.date.accessioned2003-05-22en_US
dc.date.accessioned2009-06-03T07:13:52Z
dc.date.available2003-05-22en_US
dc.date.available2009-06-03T07:13:52Z
dc.date.issued2003-05-22en_US
dc.identifier.citationNagral A. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha. National Medical Journal of India. 2003 May-Jun; 16(3): 175; author reply 175-6en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/119576
dc.language.isoengen_US
dc.source.urihttps://www.nmji.inen_US
dc.subject.meshAntiviral Agents --economicsen_US
dc.subject.meshCost-Benefit Analysisen_US
dc.subject.meshDeveloping Countriesen_US
dc.subject.meshDisease Progressionen_US
dc.subject.meshDrug Costsen_US
dc.subject.meshHepatitis B, Chronic --drug therapyen_US
dc.subject.meshHumansen_US
dc.subject.meshIndiaen_US
dc.subject.meshInterferon-alpha --economicsen_US
dc.subject.meshQuality of Lifeen_US
dc.subject.meshTreatment Outcomeen_US
dc.titleCost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.en_US
dc.typeCommenten_US
dc.typeLetteren_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
National Medical Journal of India